Russian company presents COVID-19 treatment drug to Vietnam

Sunday, 2021-09-12 20:44:16
 Font Size:     |        Print

The shipment comprises of 2,376 boxes of Cytoflavin treatment drug (Photo:
 Font Size:     |  

NDO/VNA - The Polysan Science & Technology Company in Saint-Petersburg has decided to grant a batch of Cytoflavin drug that is able to treat around 1,000 COVID-19 patients to the Vietnamese Ministry of Defence.

This is the outcomes of meetings between Vietnam’s Defence Attaché Office in Russia and the Government Committee for the External Relations of Saint-Petersburg and the company.

The shipment comprises of a total of 2,376 boxes of Cytoflavin treatment drug.

Cytoflavin is currently being used as part of the treatment regimen for COVID-19 patients in Russia and typically used for the prevention of acute ischemic stroke.

Russian doctors also make use of this drug to treat cardiovascular and brain complications detected in COVID-19 patients.

Speaking at the handover ceremony, Attaché Colonel Tran Tien Phuong expressed his sincere thanks for this gift, adding that the invaluable support will help deal with the pandemic in Vietnam while contributing to further enhancing the comprehensive strategic partnership between the two countries.